In interferon-γ-treated cancer cells, cytoplasmic HSP90α acts as a chaperone protecting JAK1/2 from degradation and thus enhances STAT-1 phosphorylation and the downstream gene expressions [33]. Here, HSP90AA1 is linked to cancer.